UCB · 2 hours ago
Health Economics Outcomes Research & Real World Evidence Lead
Atlanta, Georgia, US
Full-time
Hybrid
Senior Level
$164K/yr - $215K/yr
5+ years expUCB is a global biopharmaceutical company focusing on neurology and immunology. They are seeking a Health Economics Outcomes Research & Real World Evidence Lead to manage research programs that generate scientific evidence for UCB Immunology products, collaborating with internal teams and external healthcare providers.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Execute Immunology RWE and HEOR research projects by identifying the most appropriate dataset based on research objectives, writing study protocols and statistical analysis plans, obtaining approval from protocol review committee, and study execution inclusive of analytical oversight, data interpretation, and creation of final reports
Relevant research activities which may include, but not be limited to:
Prospective observational, pragmatic clinical trials, and/or patient registries evaluating clinical, patient-centered, and/or economic endpoints
Retrospective studies of existing databases to assess patient characteristics, treatment patterns, and associated clinical, economic and/or patient-reported outcomes
Retrospective or prospective evaluations of disease natural history and treatment patterns, including drug utilization and adherence
Surveys of patients, caregivers, health care providers/practitioners, and/or payers
Assessments exploring burden of illness and/or comparative effectiveness
Models of cost-effectiveness and budget impact
Review outcomes research protocols, statistical analysis plans (SAPs), and reports
Review, and publish scientific reports reflecting ongoing or completed work
Contributes to the evidence generation plan and provide RWE/HEOR inputs to the brand planning and budgeting processes and formulate recommended strategies in support of asset value proposition in collaboration with the internal teams
Provides input on clinical trial design from a RWE/HEOR perspective and ensure inclusion of appropriate health economic endpoints into clinical trials to maximize asset value proposition in collaboration with the clinical development team
Keeps abreast of the trends in Immunology RWE/HEOR and proactively address RWE/HEOR strategy changes in anticipation of these trends
Collaborates with scientific communications to provide RWE/HEOR input on scientific platform and develop RWE/HEOR-related scientific publications
Designs and conducts real-world evidence studies to ensure timely quantitative understanding of economic, humanistic and clinical burden of disease, disease sequelae and patient journey to enhance patient access
Authors protocols, reports and other study documents with independent, critical thinking to ensure quality and completeness of output, oversees timeline for deliverables associated with analysis and reporting
Qualification
Required
Master's degree (MS, MPH) in health services research, public health policy, epidemiology, economics, social psychology, medicine, pharmacy or statistics with medical training/experience in the conduct of econometric and patient-reported outcome research to evaluate the impact of health care interventions
5+ years of experience in health services research, public health, epidemiology, or health economics
Experience with post-marketing 'real world evidence' studies and registries
Preferred
Doctorate degree (Ph.D., PharmD, MD)
At least one year of experience within the immunology therapeutic area
Experience with large data-base analyses and use of patient-reported outcomes instruments
Company
UCB
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease.
5001-10000 employees
H1B Sponsorship
UCB has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (7)
2023 (3)
2022 (4)
2021 (4)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$201.75MKey Investors
Financière de Tubize SAPaul Capital
2022-05-23Post Ipo Equity· $100.96M
2015-05-13Post Ipo Equity· $0.79M
2009-12-22Post Ipo Equity· $100M
Leadership Team
Jean-Christophe Tellier
CEO
Stefanos Grammatikos
Senior Vice President - Head of CMC Development Sciences
Recent News
Company data provided by crunchbase